MLYS logo

Mineralys Therapeutics (MLYS) Free Cash Flow

Annual FCF

-$166.41 M
-$85.24 M-105.01%

December 31, 2024


Summary


Performance

MLYS Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMLYScash flowmetrics:

Quarterly FCF

-$66.84 M
-$16.62 M-33.09%

December 31, 2024


Summary


Performance

MLYS Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMLYScash flowmetrics:

TTM FCF

-$166.41 M
-$37.86 M-29.45%

December 31, 2024


Summary


Performance

MLYS TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMLYScash flowmetrics:

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

MLYS Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-105.0%-130.6%-105.0%
3 y3 years-1043.0%-130.6%-105.0%
5 y5 years-6656.4%-130.6%-105.0%

MLYS Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1043.0%at low-1122.2%at low-2429.8%at low
5 y5-year-6656.4%at low-1122.2%at low-2429.8%at low
alltimeall time-6656.4%at low-1122.2%at low-2429.8%at low

Mineralys Therapeutics Free Cash Flow History

DateAnnualQuarterlyTTM
Dec 2024
-$166.41 M(+105.0%)
-$66.84 M(+33.1%)
-$166.41 M(+29.5%)
Sep 2024
-
-$50.22 M(+66.6%)
-$128.55 M(+32.0%)
Jun 2024
-
-$30.15 M(+57.0%)
-$97.36 M(+11.1%)
Mar 2024
-
-$19.20 M(-33.8%)
-$87.60 M(+7.9%)
Dec 2023
-$81.17 M
-$28.98 M(+52.3%)
-$81.17 M(+30.1%)
Sep 2023
-
-$19.03 M(-6.6%)
-$62.38 M(+23.9%)
Jun 2023
-
-$20.39 M(+59.6%)
-$50.34 M(+42.1%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$12.78 M(+25.4%)
-$35.42 M(+21.2%)
Dec 2022
-$29.22 M(+100.7%)
-$10.19 M(+45.8%)
-$29.22 M(+53.5%)
Sep 2022
-
-$6.99 M(+27.8%)
-$19.04 M(+58.0%)
Jun 2022
-
-$5.47 M(-16.9%)
-$12.05 M(+83.1%)
Mar 2022
-
-$6.58 M
-$6.58 M
Dec 2021
-$14.56 M(+491.1%)
-
-
Dec 2020
-$2.46 M
-
-

FAQ

  • What is Mineralys Therapeutics annual free cash flow?
  • What is the all time high annual FCF for Mineralys Therapeutics?
  • What is Mineralys Therapeutics annual FCF year-on-year change?
  • What is Mineralys Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for Mineralys Therapeutics?
  • What is Mineralys Therapeutics quarterly FCF year-on-year change?
  • What is Mineralys Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for Mineralys Therapeutics?
  • What is Mineralys Therapeutics TTM FCF year-on-year change?

What is Mineralys Therapeutics annual free cash flow?

The current annual FCF of MLYS is -$166.41 M

What is the all time high annual FCF for Mineralys Therapeutics?

Mineralys Therapeutics all-time high annual free cash flow is -$2.46 M

What is Mineralys Therapeutics annual FCF year-on-year change?

Over the past year, MLYS annual free cash flow has changed by -$85.24 M (-105.01%)

What is Mineralys Therapeutics quarterly free cash flow?

The current quarterly FCF of MLYS is -$66.84 M

What is the all time high quarterly FCF for Mineralys Therapeutics?

Mineralys Therapeutics all-time high quarterly free cash flow is -$5.47 M

What is Mineralys Therapeutics quarterly FCF year-on-year change?

Over the past year, MLYS quarterly free cash flow has changed by -$37.86 M (-130.64%)

What is Mineralys Therapeutics TTM free cash flow?

The current TTM FCF of MLYS is -$166.41 M

What is the all time high TTM FCF for Mineralys Therapeutics?

Mineralys Therapeutics all-time high TTM free cash flow is -$6.58 M

What is Mineralys Therapeutics TTM FCF year-on-year change?

Over the past year, MLYS TTM free cash flow has changed by -$85.24 M (-105.01%)